This drug combo cuts death-risk in cancer cases by 58%

Amgen's Imdelltra, an immunotherapy drug, has been found to significantly increase survival rates in patients with aggressive small cell lung cancer (SCLC) when used with AstraZeneca's Imfinzi.
Read the full report on Newsbytes
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Newsbytes
- Reporter
- dwaipayan roy
- Published
- Sunday, 25 October 2026, 11:37 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Newsbytes with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

